LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.79 | 17.25 | 908 | 1001 | 0.9065 | 0.9668 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.79 | 17.25 | 1041 | 1001 | 1.0393 | 1.0132 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.76 | 17.25 | 909 | 1193 | 0.7616 | 0.9128 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.76 | 17.25 | 1065 | 1193 | 0.8923 | 0.9631 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.73 | 17.25 | 962 | 1290 | 0.7456 | 0.9079 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.73 | 17.25 | 1101 | 1290 | 0.8534 | 0.9497 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 26.70 | 17.25 | 1029 | 1466 | 0.7016 | 0.8924 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 26.70 | 17.25 | 1149 | 1466 | 0.7834 | 0.9253 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 28.67 | 17.25 | 1100 | 1653 | 0.6654 | 0.8800 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 28.67 | 17.25 | 1225 | 1653 | 0.7410 | 0.9110 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 30.64 | 17.25 | 1 | 1887 | 0.0005 | -0.3433 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 30.64 | 17.25 | 1152 | 1887 | 0.6104 | 0.8594 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 30.64 | 17.25 | 1 | 1887 | 0.0005 | -0.3433 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 30.64 | 17.25 | 1294 | 1887 | 0.6856 | 0.8916 | MN20160310_N02 | L16 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 32.61 | 17.25 | 1 | 2136 | 0.0005 | -0.3361 | MN20160310_N02 | F13 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 32.61 | 17.25 | 1207 | 2136 | 0.5650 | 0.8423 | MN20160310_N02 | F13 |